A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results Meeting Abstract
| Authors: | Segal, N. H.; Girda, E.; Sohal, D.; Lakhani, N. J.; Olszanski, A. J.; Fong, L.; Kinnaman, M. D.; Han, H.; Skokos, D.; Casey, K. A.; Wang, J. A.; Wang, B.; Hao, Y.; Li, S.; Ganguly, S.; Lowy, I.; Seebach, F. A.; Mathias, M. D.; Johnson, M. L. |
| Abstract Title: | A phase 1/2 study of REGN7075 in combination with cemiplimab (cemi) in patients (pts) with advanced solid tumors: Efficacy and safety results |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400450 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.2503 |
| Notes: | Meeting Abstract: 2503 -- Source: Wos |
